Avalo Therapeutics at Stifel 2026 Healthcare Conference: phase iii ahead
AI Summary
Avalo Therapeutics is scheduled to present at the Stifel 2026 Healthcare Conference, with the headline highlighting progress toward Phase III. The article description provides no additional details about the company's clinical program or conference remarks.